Major Networks

Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy

Atai Life Sciences, a Germany-based biopharmaceutical company, has become the latest publicly traded firm to adopt a Bitcoin treasury strategy.

Mar 21, 2025 - 04:24
Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy
BTC BitcoinAtai Life Sciences, a Germany-based biopharmaceutical company, has become the latest publicly traded firm to adopt a Bitcoin treasury strategy.
Read More

Tags:

Previous Article

Crypto Price Today: Bitcoin at $84,695, XRP Jumps 6.17% Weekly After Ripple's Le...

Next Article

North Korean Hackers' Bitcoin Holdings Outstrip Tesla's, With Lazarus Group Now ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Long-term Bitcoin Holders Grow Balances as Mining Supply Decreases

Long-term Bitcoin Holders Grow Balances as Mining Suppl...

Oct 29, 2024

4 Highest Potential Cryptos in 2025: Bitcoin, Render, BlockDAG & ThorChain— Next Bull Run Awaits!

4 Highest Potential Cryptos in 2025: Bitcoin, Render, B...

Mar 21, 2025

La Rosa Holdings to offer Bitcoin payments for real estate agents

La Rosa Holdings to offer Bitcoin payments for real est...

Dec 23, 2024